GILD
GILEAD SCIENCES, INC.
NASDAQ · Healthcare · Drug Manufacturers - General · US
$150.11
−0.52%Leverage
- Debt / equity
- 2.22x
- Net debt / equity
- 1.95x
- Debt / assets
- 0.53x
- Debt / EBITDA
- 41.27x
- Net debt / EBITDA
- 36.27x
Liquidity & coverage
- Current ratio
- 1.27x
- Quick ratio
- 1.09x
- Cash ratio
- 0.29x
- Interest coverage
- -1.50x
- EBITDA / interest
- 0.64x
- Working capital
- $2.9B
Cash & dividend
- FCF / debt
- 0.50x
- Cash flow / debt
- 0.52x
- Dividend per share
- $2.46
- Dividend yield
- 1.6%
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026